Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Miguel D. Ferrer(Universidad de Zaragoza), Xavier Capó(Research Institute of Health Sciences), Josep A. Tur(Instituto de Salud Carlos III), Carla Busquets-Cortés(Research Institute of Health Sciences), Antoni Pons(Instituto de Salud Carlos III), Silvia Tejada(Universitat de les Illes Balears)
Cited by 242
Related Papers
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325
Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial
|Nutrition Metabolism and Cardiovascular Diseases|2014|199
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial
|Journal of the International Society of Sports Nutrition|2014|150
Acute Administration of Inorganic Nitrate Reduces V˙O2peak in Endurance Athletes
|Medicine & Science in Sports & Exercise|2011|137
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
|European Respiratory Journal|2011|124